Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss benefits in multiple large-scale clinical trials. Real-world weight loss on semaglutide ranges widely depending on individual factors including starting weight, dose escalation, diet quality, physical activity, and genetic predisposition to GLP-1 sensitivity. Understanding what research shows about typical outcomes can help set realistic expectations for your personal weight loss journey.

Clinical Trial Data on Semaglutide Weight Loss Results

The STEP trials, which evaluated semaglutide for weight management in non-diabetic adults, documented impressive average weight loss across different dose levels. Participants receiving 2.4 mg of semaglutide weekly lost approximately 15% of their body weight over 68 weeks of treatment, while those on lower doses achieved 5–11% reductions. For example, a person weighing 250 pounds might expect to lose 37–54 pounds at the highest dose, though individual results ranged from minimal loss to reductions exceeding 50 pounds.

Notably, weight loss on semaglutide typically accelerates during the first 6–12 months of treatment, with continued gradual reductions through month 18. Many participants experienced their most significant losses in the first 3 months as their appetite hormones stabilized and food cravings diminished. The plateau effect—where weight loss slows after an initial phase—is a normal physiological response and does not indicate treatment failure.

Why Individual Weight Loss Varies on Semaglutide

Not everyone loses the same amount of weight on semaglutide because human metabolism, insulin sensitivity, and appetite regulation involve dozens of genes and hormonal pathways. A person's baseline metabolic rate, previous dieting history, stress levels, sleep quality, and adherence to dose increases all meaningfully influence final weight loss outcomes. Someone who reaches the full 2.4 mg dose and combines treatment with consistent physical activity typically sees stronger results than someone who stabilizes at a lower dose or makes minimal lifestyle adjustments.

Genetic variants affecting GLP-1 receptor function, appetite suppression pathways, and fat storage directly predict how responsive an individual will be to semaglutide therapy. PlexusDx's Precision Peptide Genetic Test evaluates 14 metabolic pathways and 49 peptides, including key markers like GLP1R rs6923761 and GIPR rs1800437, to identify which individuals show genetic predisposition for optimal GLP-1 responsiveness. This personalized genetic insight helps optimize dosing and medication selection before investing in months of treatment.

Realistic Weight Loss Expectations During Your First Year

Most people experience noticeable appetite reduction and early weight loss within the first 2–4 weeks of starting semaglutide, though weight change on a scale may lag behind reduced food intake by a few weeks. By month 3, many individuals report 5–10 pounds of weight loss; by month 6, cumulative losses typically range from 10–25 pounds depending on starting weight and dose level. Reaching the therapeutic dose of 2.4 mg usually takes 4–5 months due to gradual dose escalation protocols designed to minimize gastrointestinal side effects.

Beyond the first year, continued weight loss often slows but can persist through month 18 as the body stabilizes at a lower set point. Some individuals plateau after losing 15–20% of initial body weight, while others continue dropping pounds into month 24 of treatment. Sustained results depend heavily on maintaining medication adherence, eating practices learned during early treatment, and ongoing physical activity—semaglutide is most effective when combined with behavioral changes rather than relied upon as a standalone solution.

How PlexusDx Compounded Semaglutide Supports Long-Term Weight Management

PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies, offering consistent dosing and quality at a fixed monthly price starting at $149/mo—without flat per-compound pricing increases. Whether you're using 0.5 mg weekly, 1.0 mg weekly, or the full 2.4 mg therapeutic dose, your monthly cost remains flat, ensuring that dose optimization never becomes financially prohibitive. This pricing structure removes a common barrier to reaching therapeutic doses that maximize weight loss potential.

PlexusDx patients across all 50 states access telehealth evaluations, personalized treatment plans, and optional genetic testing to understand their individual metabolic profile. The Precision Peptide Genetic Test identifies your genetic predispositions for GLP-1 responsiveness before committing to long-term therapy, helping confirm whether semaglutide or tirzepatide may deliver stronger results in your specific case. HSA and FSA accounts cover PlexusDx medications, and no insurance verification or membership fees apply, making precision weight loss therapy accessible regardless of insurance status.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I lose 50+ pounds on semaglutide?

Yes—clinical trial participants with higher starting weights and full dose adherence have achieved weight losses exceeding 50 pounds. However, weight loss of this magnitude typically requires reaching and maintaining the 2.4 mg weekly dose, combining treatment with consistent lifestyle changes, and treating for at least 12–18 months. Your individual potential depends on starting weight, genetics, and medication responsiveness.

How does semaglutide cause weight loss on a cellular level?

Semaglutide activates GLP-1 receptors in the brain and gut, which regulate hunger hormones, increase feelings of fullness, slow stomach emptying, and reduce cravings for high-calorie foods. This dual action on appetite signaling and metabolic rate produces sustained weight loss over time. Genetic variations in GLP1R and related pathways predict how strongly your body will respond to this mechanism.

How much does PlexusDx semaglutide cost compared to branded Wegovy?

PlexusDx compounded semaglutide injections start at $149/mo and remain flat regardless of dose level—your price won't go up as your dose increases. Branded Wegovy typically costs $900–$1,300 per month without insurance. PlexusDx medications are HSA/FSA eligible and available in all 50 states without insurance requirements.

Are there side effects that slow weight loss or require stopping treatment?

Most semaglutide side effects—nausea, constipation, mild fatigue—occur during dose escalation and typically subside within days to weeks as your body adapts. Serious adverse events are rare at weight-management doses. Some individuals experience gastrointestinal effects that prompt dose reduction, which may slow weight loss but remains manageable with proper monitoring.

What does the PlexusDx Precision Peptide Genetic Test reveal about my weight loss potential?

PlexusDx's $99 genetic test (available after first month of treatment) analyzes 49 peptides across 14 metabolic pathways, including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These variants predict your genetic predisposition for GLP-1 responsiveness, fat storage tendency, and appetite regulation strength—helping confirm whether semaglutide or tirzepatide may deliver optimal results in your specific genetic profile.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves